Loading company…
Boston-based biotechnology company developing therapeutics that help the body rebuild tissue by modulating RHAMM.
Based in Boston, US, Novare Pharmaceuticals develops therapeutic products that help the body replenish and rebuild itself using its own tissue, through modulation of the Receptor for Hyaluronan Mediated Motility (RHAMM). It is listed at the Seed stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in